1. Home
  2. AKTX vs SHOT Comparison

AKTX vs SHOT Comparison

Compare AKTX & SHOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AKTX
  • SHOT
  • Stock Information
  • Founded
  • AKTX N/A
  • SHOT 2018
  • Country
  • AKTX United States
  • SHOT United States
  • Employees
  • AKTX N/A
  • SHOT N/A
  • Industry
  • AKTX Biotechnology: Pharmaceutical Preparations
  • SHOT Biotechnology: Pharmaceutical Preparations
  • Sector
  • AKTX Health Care
  • SHOT Health Care
  • Exchange
  • AKTX Nasdaq
  • SHOT Nasdaq
  • Market Cap
  • AKTX 37.2M
  • SHOT 30.4M
  • IPO Year
  • AKTX N/A
  • SHOT 2020
  • Fundamental
  • Price
  • AKTX $1.14
  • SHOT $0.43
  • Analyst Decision
  • AKTX
  • SHOT
  • Analyst Count
  • AKTX 0
  • SHOT 0
  • Target Price
  • AKTX N/A
  • SHOT N/A
  • AVG Volume (30 Days)
  • AKTX 26.9K
  • SHOT 6.3M
  • Earning Date
  • AKTX 08-18-2025
  • SHOT 08-13-2025
  • Dividend Yield
  • AKTX N/A
  • SHOT N/A
  • EPS Growth
  • AKTX N/A
  • SHOT N/A
  • EPS
  • AKTX N/A
  • SHOT N/A
  • Revenue
  • AKTX N/A
  • SHOT $573,336.00
  • Revenue This Year
  • AKTX N/A
  • SHOT N/A
  • Revenue Next Year
  • AKTX N/A
  • SHOT N/A
  • P/E Ratio
  • AKTX N/A
  • SHOT N/A
  • Revenue Growth
  • AKTX N/A
  • SHOT 69.32
  • 52 Week Low
  • AKTX $0.85
  • SHOT $0.23
  • 52 Week High
  • AKTX $4.40
  • SHOT $1.77
  • Technical
  • Relative Strength Index (RSI)
  • AKTX 43.82
  • SHOT 54.76
  • Support Level
  • AKTX $1.10
  • SHOT $0.35
  • Resistance Level
  • AKTX $1.18
  • SHOT $0.48
  • Average True Range (ATR)
  • AKTX 0.05
  • SHOT 0.06
  • MACD
  • AKTX 0.00
  • SHOT 0.01
  • Stochastic Oscillator
  • AKTX 39.52
  • SHOT 46.94

About AKTX Akari Therapeutics plc ADS

Akari Therapeutics PLC is an oncology company developing next-generation antibody-drug conjugates (ADCs) designed around novel, proprietary cancer-killing toxins (payloads). The company believes these novel payloads may have the potential to transform the efficacy and safety outcomes of ADCs as cancer therapies beyond options that are currently available or in development. Its lead product candidate is AKTX-101, a preclinical stage Trop2-targeting ADC that combines PH1 with the Trop2 antibody, which is expressed in the highest number of solid tumor cancer types, including lung, breast, colon and prostate.

About SHOT Safety Shot Inc.

Safety Shot Inc is a wellness and functional beverage company. It is set to launch Safety Shot, the patented beverage that helps people feel faster by reducing blood alcohol content and boosting clarity.

Share on Social Networks: